二叶式主动脉瓣综合征中异质性升主动脉瘤行主动脉根部手术的长期结局
该研究纳入1997至2017年635例择期行根部复合手术的二叶式主动脉瓣患者,按瓣膜病变和动脉瘤表型分层并用逆概率加权调整基线差异。结果显示Bentall与AVRSCAAR全因死亡率无差异,生物型AVRSCAAR卒中风险显著降低,VSRR死亡率改善但主动脉瓣反流复发更高。个体化选择Bentall、AVRSCAAR和VSRR可获得良好长期临床与功能结局。
要点
- 主动脉瓣狭窄患者中,生物型AVRSCAAR较机械瓣显著降低卒中风险(HR 0.04,P=.013)。
- 主动脉瓣反流患者中,生物型AVRSCAAR组卒中风险较低且主动脉再手术率较低(系数<0.01,P<.001)。
- VSRR较Bentall死亡率显著改善(HR 0.12,P=.022),但中度及以上主动脉瓣反流复发更高(β=2.63,P<.001)。
核心结论
- 针对二叶式主动脉瓣综合征中异质性升主动脉瘤病理,采用Bentall、AVRSCAAR和VSRR的个体化术式可获得良好的长期临床与功能结局,生物型管道显示等效至更优的临床结局。
研究设计与样本
- 1997年至2017年纳入635例择期行根部复合手术的二叶式主动脉瓣患者,按瓣膜病变(主动脉瓣狭窄 vs 主动脉瓣反流)分层,并再按升主动脉或根部动脉瘤表型亚分层,采用逆概率加权调整基线差异。
主要发现
- Bentall与AVRSCAAR的全因死亡率Kaplan-Meier曲线在主动脉瓣狭窄和主动脉瓣反流表现中均无差异(log-rank P > .05)。
- 主动脉瓣狭窄患者中,多变量Cox回归显示生物型AVRSCAAR卒中风险显著降低(风险比0.04,P=.013)。
- 生物瓣与机械瓣的主动脉再手术率相似(P=.353)。
- 主动脉瓣反流患者中,长期死亡率相似(风险比0.95,P=.93),但Cox回归显示生物型AVRSCAAR组卒中风险较低,且主动脉再手术率较低(系数<0.01,P<.001)。
- Bentall与VSRR比较,VSRR患者死亡率显著改善(风险比0.12,P=.022),但多状态模型显示VSRR中度及以上主动脉瓣反流复发更高(β系数2.63,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgery for ascending aneurysms in bicuspid aortic valve syndrome primarily includes Bentall root replacement, aortic valve replacement with supracoronary ascending aorta replacement (AVRSCAAR), and valve-sparing root reimplantation (VSRR). Comparative analysis of long-term clinical and functional outcomes of these procedures is detailed. METHODS: From 1997 to 2017, 635 patients with bicuspid aortic valve undergoing root complex-focused procedures electively were stratified by valvulopathy (ie, aortic stenosis vs aortic insufficiency) and substratified into ascending or root aneurysm phenotype. Inverse probability weights were calculated to adjust for baseline differences. RESULTS: Kaplan-Meier curves for all-cause mortality demonstrated no difference between Bentall versus AVRSCAAR for aortic stenosis and aortic insufficiency presentations (log-rank P > .05). In patients with aortic stenosis, multivariable Cox regression showed significantly decreased risk of stroke for biologic AVRSCAAR (hazard ratio, 0.04; P = .013). Aortic reoperation rates were similar for biologic versus mechanical valves (P = .353). In patients with aortic insufficiency, similar long-term mortality (hazard ratio, 0.95; P = .93), but lower stroke risk in biologic AVRSCAAR group by Cox regression, and lower aortic reoperation rate was noted (coefficient < 0.01; P < .001). Comparing Bentall to VSRR, mortality (hazard ratio, 0.12; P = .022) was significantly improved in patients undergoing VSRR, but recurrence of moderate or greater aortic insufficiency was higher in VSRR by multistate model (beta coefficient 2.63; P < .001). CONCLUSIONS: A tailored approach to heterogeneous ascending aneurysm pathologies in bicuspid aortic valve syndrome utilizing Bentall, AVRSCAAR, and VSRR procedures renders excellent long-term clinical and functional outcomes, with biologic conduits showing equivalent to improved clinical outcomes.
引用
- Karianna Milewski RC, Habertheuer A, Bavaria JE, et al. Long-term outcomes of aortic root procedures for heterogenous ascending aneurysm disease in bicuspid aortic valve syndrome. J Thorac Cardiovasc Surg. 2022. PMID: 36631305. doi:10.1016/j.jtcvs.2022.09.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。